Tuesday, November 27, 2007

Coronary slow flow phenomenon (CSFP): an emerging cause of chest pain with “normal” coronary arteries

A case report and review of the literature appeared in Clinical Cardiology.

Key points:

This poorly understood disorder is not cardiac syndrome X and is not always a benign disorder.

Abnormal QT interval dispersion and life threatening cardiac arrhythmias may be associated.

Dipyridamole is a potential treatment.

2 comments:

Anonymous said...

I have CSFP and was on a drug trial testing Posicor (mibefradil) with great success. Unfortunately it has been withdrawn from the market and to date my cardiologists and I have not found anything that works as effective. I trialled Dipyridamole which controlled my chest pain a little, but the side effects were so horrendous I was taken off the trial.
Although I have 'normal' coronary arteries and have been assured there is little chance of an infarct, the fact is the phenomenon has significantly effected my quality of life, particularly during 'flare-ups'.
Chris C, Australia

JOYPREACHER said...

Diagnosed with csfp and have taken dipyridamole for a year. No results. Now instead of just pressure, I have a "burning" sensation on top of the pressure. Any hope out there? Life affecting problem with no apparent solution.